Atrial natriuretic peptide is a physiological inhibitor of ACTH release

Evidence from immunoneutralization in vivo

G. Fink, R. C. Dow, D. Casley, C. I. Johnston, A. T. Lim, D. L. Copolov, J. Bennie, S. Carroll, H. Dick

Research output: Contribution to journalArticleResearchpeer-review

68 Citations (Scopus)

Abstract

The brain is thought to exert a predominantly stimulatory action of ACTH secretion mediated mainly by corticotrophin-releasing factor-41 (CRF-41) and arginine vasopressin (AVP). Several data, however, also point to the existence of an ACTH-inhibiting factor. Atrial natriuretic peptide (ANP), at concentrations found in hypophysial portal blood, inhibits ACTH release in vitro. The aim of the present studies was to use ANP immunoneutralization to determine whether ANP does in fact inhibit ACTH release in vivo. Intracerebroventricular infusion (1 μl/min for 30 min) of sheep anti-ANP serum into male rats anaesthetized with sodium pentobarbitone had no significant effect on jugular venous plasma concentrations of ACTH or LH but did decrease significantly the plasma concentrations of prolactin. Intravenous infusion of 0.8 ml sheep anti-ANP serum but not control (non-immune) sheep serum, through an indwelling intra-arterial cannula in conscious male rats resulted in a marked and significant increase in plasma ACTH and corticosterone concentrations. The ACTH and corticosterone response to a 30-s ether stress was not significantly potentiated in the same conscious rats infused with anti-ANP serum. Intra-artrial infusion of anti-ANP did not significantly affect plasma prolactin, LH, glucose or sodium concentrations or plasma osmolality. These results show for the first time that ANP is a potent inhibitor of ACTH secretion in the conscious male rat and that, therefore, ANP is a hypothalamic neurohormone which is likely to play an important inhibitory role in the neural control of ACTH release.

Original languageEnglish
JournalJournal of Endocrinology
Volume131
Issue number3
Publication statusPublished - 1 Jan 1991
Externally publishedYes

Cite this

Fink, G. ; Dow, R. C. ; Casley, D. ; Johnston, C. I. ; Lim, A. T. ; Copolov, D. L. ; Bennie, J. ; Carroll, S. ; Dick, H. / Atrial natriuretic peptide is a physiological inhibitor of ACTH release : Evidence from immunoneutralization in vivo. In: Journal of Endocrinology. 1991 ; Vol. 131, No. 3.
@article{30d1cab12ea44c2cad7e1517a3f7eade,
title = "Atrial natriuretic peptide is a physiological inhibitor of ACTH release: Evidence from immunoneutralization in vivo",
abstract = "The brain is thought to exert a predominantly stimulatory action of ACTH secretion mediated mainly by corticotrophin-releasing factor-41 (CRF-41) and arginine vasopressin (AVP). Several data, however, also point to the existence of an ACTH-inhibiting factor. Atrial natriuretic peptide (ANP), at concentrations found in hypophysial portal blood, inhibits ACTH release in vitro. The aim of the present studies was to use ANP immunoneutralization to determine whether ANP does in fact inhibit ACTH release in vivo. Intracerebroventricular infusion (1 μl/min for 30 min) of sheep anti-ANP serum into male rats anaesthetized with sodium pentobarbitone had no significant effect on jugular venous plasma concentrations of ACTH or LH but did decrease significantly the plasma concentrations of prolactin. Intravenous infusion of 0.8 ml sheep anti-ANP serum but not control (non-immune) sheep serum, through an indwelling intra-arterial cannula in conscious male rats resulted in a marked and significant increase in plasma ACTH and corticosterone concentrations. The ACTH and corticosterone response to a 30-s ether stress was not significantly potentiated in the same conscious rats infused with anti-ANP serum. Intra-artrial infusion of anti-ANP did not significantly affect plasma prolactin, LH, glucose or sodium concentrations or plasma osmolality. These results show for the first time that ANP is a potent inhibitor of ACTH secretion in the conscious male rat and that, therefore, ANP is a hypothalamic neurohormone which is likely to play an important inhibitory role in the neural control of ACTH release.",
author = "G. Fink and Dow, {R. C.} and D. Casley and Johnston, {C. I.} and Lim, {A. T.} and Copolov, {D. L.} and J. Bennie and S. Carroll and H. Dick",
year = "1991",
month = "1",
day = "1",
language = "English",
volume = "131",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Bioscientifica",
number = "3",

}

Atrial natriuretic peptide is a physiological inhibitor of ACTH release : Evidence from immunoneutralization in vivo. / Fink, G.; Dow, R. C.; Casley, D.; Johnston, C. I.; Lim, A. T.; Copolov, D. L.; Bennie, J.; Carroll, S.; Dick, H.

In: Journal of Endocrinology, Vol. 131, No. 3, 01.01.1991.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Atrial natriuretic peptide is a physiological inhibitor of ACTH release

T2 - Evidence from immunoneutralization in vivo

AU - Fink, G.

AU - Dow, R. C.

AU - Casley, D.

AU - Johnston, C. I.

AU - Lim, A. T.

AU - Copolov, D. L.

AU - Bennie, J.

AU - Carroll, S.

AU - Dick, H.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The brain is thought to exert a predominantly stimulatory action of ACTH secretion mediated mainly by corticotrophin-releasing factor-41 (CRF-41) and arginine vasopressin (AVP). Several data, however, also point to the existence of an ACTH-inhibiting factor. Atrial natriuretic peptide (ANP), at concentrations found in hypophysial portal blood, inhibits ACTH release in vitro. The aim of the present studies was to use ANP immunoneutralization to determine whether ANP does in fact inhibit ACTH release in vivo. Intracerebroventricular infusion (1 μl/min for 30 min) of sheep anti-ANP serum into male rats anaesthetized with sodium pentobarbitone had no significant effect on jugular venous plasma concentrations of ACTH or LH but did decrease significantly the plasma concentrations of prolactin. Intravenous infusion of 0.8 ml sheep anti-ANP serum but not control (non-immune) sheep serum, through an indwelling intra-arterial cannula in conscious male rats resulted in a marked and significant increase in plasma ACTH and corticosterone concentrations. The ACTH and corticosterone response to a 30-s ether stress was not significantly potentiated in the same conscious rats infused with anti-ANP serum. Intra-artrial infusion of anti-ANP did not significantly affect plasma prolactin, LH, glucose or sodium concentrations or plasma osmolality. These results show for the first time that ANP is a potent inhibitor of ACTH secretion in the conscious male rat and that, therefore, ANP is a hypothalamic neurohormone which is likely to play an important inhibitory role in the neural control of ACTH release.

AB - The brain is thought to exert a predominantly stimulatory action of ACTH secretion mediated mainly by corticotrophin-releasing factor-41 (CRF-41) and arginine vasopressin (AVP). Several data, however, also point to the existence of an ACTH-inhibiting factor. Atrial natriuretic peptide (ANP), at concentrations found in hypophysial portal blood, inhibits ACTH release in vitro. The aim of the present studies was to use ANP immunoneutralization to determine whether ANP does in fact inhibit ACTH release in vivo. Intracerebroventricular infusion (1 μl/min for 30 min) of sheep anti-ANP serum into male rats anaesthetized with sodium pentobarbitone had no significant effect on jugular venous plasma concentrations of ACTH or LH but did decrease significantly the plasma concentrations of prolactin. Intravenous infusion of 0.8 ml sheep anti-ANP serum but not control (non-immune) sheep serum, through an indwelling intra-arterial cannula in conscious male rats resulted in a marked and significant increase in plasma ACTH and corticosterone concentrations. The ACTH and corticosterone response to a 30-s ether stress was not significantly potentiated in the same conscious rats infused with anti-ANP serum. Intra-artrial infusion of anti-ANP did not significantly affect plasma prolactin, LH, glucose or sodium concentrations or plasma osmolality. These results show for the first time that ANP is a potent inhibitor of ACTH secretion in the conscious male rat and that, therefore, ANP is a hypothalamic neurohormone which is likely to play an important inhibitory role in the neural control of ACTH release.

UR - http://www.scopus.com/inward/record.url?scp=0025790177&partnerID=8YFLogxK

M3 - Article

VL - 131

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 3

ER -